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earliest  discovered  members  of  the  wider  rhomboid-like  superfamily  of proteases  and  pseudoproteases.
The  secretase  class  of  rhomboid  proteases,  distributed  through  the secretory  pathway,  are  the most
numerous  in  eukaryotes,  but  our knowledge  of them  is limited.  Here  we  aim  to summarise  all  that  has
been published  on  secretase  rhomboids  in  a concise  encyclopaedia  of the  enzymes,  their  substrates,  and
their biological  roles.  We  also  discuss  emerging  themes  of  how  these  important  enzymes  are  regulated.
© 2016  The  Authors.  Published  by Elsevier  Ltd. This  is an open  access  article  under  the  CC BY  license
(http://creativecommons.org/licenses/by/4.0/).
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. Introduction
Classical proteases are some of the most studied and best
nderstood enzymes, but intramembrane proteases are much more
ecently discovered and quite different from their soluble coun-
erparts. Arising by convergent evolution, and unrelated to the
lassical proteases, all intramembrane proteases have multiple
ransmembrane domains (TMDs), active sites buried in the mem-
rane, and they all cut substrate TMDs. In general, proteases can
e divided into those whose primary job is to degrade substrates
 digestive enzymes, the proteasome, lysosomal enzymes – and
hose whose job is to separate domains of proteins, thereby mod-
fying their function, and often participating in signalling events.
lthough an important recurring theme in this review is that we
o not yet know enough about rhomboid proteases to draw very
weeping conclusions they, like other intramembrane proteases,
ppear primarily to act with high speciﬁcity and precision to control
ignalling rather than as general degradation machinery.
Rhomboids are intramembrane serine proteases that were ini-
ially discovered in Drosophila,  where Rhomboids-1 to -3 control
GFR signalling by cleaving and releasing active growth factors
rom their transmembrane pro-forms [1,2]. It subsequently became
lear that rhomboid proteases are members of a much broader
uperfamily of rhomboid-like proteins, conserved in all kingdoms
f life. The wider superfamily consists of both active proteases as
ell as a signiﬁcant subset of proteins that appear to have lost their
atalytic activity: the iRhoms and a wide range of other inactive
homboid-like proteins, including derlins [3]. The rhomboid pro-
eases can be further divided into those located along the secretory
athway and plasma membrane, the secretase class, and those in
itochondria, the PARL class [4]. Rhomboid proteases have been
xtensively studied in Drosophila and apicomplexan parasites but,
otably, very little is yet known about their functions in mammals.
s the primary function of proteases is to cleave other proteins,
he key to unlocking the biological role of rhomboids is discovering
heir substrates.
Here we focus on the most numerous class of eukaryotic rhom-
oid proteases – the secretase rhomboids. We  start with some
eneral principles, but our main goal is to provide a concise ency-
lopaedia of what is known about them across multiple organisms.
e ﬁnish with a more speculative discussion about the regulation
f these important regulatory enzymes. We  do not consider the
itochondrial rhomboids, reviewed in this issue [5], nor the role of
rokaryotic rhomboids, about which little is known.
. Rhomboids – general principles
Like all intramembrane proteases, rhomboids are polytopic
embrane proteins with their catalytic site formed of TMD  residues
ithin the lipid bilayer; the hydrolysis of the substrate peptide
ond occurs within the membrane. They are ‘serine’ proteases
ecause they use a serine as the reactive nucleophile in the pro-
eolysis reaction [1], although it is important to emphasise that
hey are evolutionarily unrelated to the classical serine proteases
ike chymotrypsin: this is an example of convergent evolution. The
ore conserved rhomboid-like domain has six TMDs, although most
ukaryotic rhomboids have an extra TMD  – located C-terminally in
he secretase rhomboids (Fig. 1), and N-terminally in the mitochon-
rial ones. Beyond the core six-TMD fold and a few highly conserved
esidues, it is notable that the similarity amongst members of the
amily is quite low [4], so it is unsafe to assume that mechanistic
nd regulatory details will necessarily be conserved. The rhomboids
ere the ﬁrst intramembrane proteases to have their atomic struc-
ure determined and this has contributed to them being the best
nderstood mechanistically [6–9].lopmental Biology 60 (2016) 10–18 11
To understand proteases, it is necessary to identify their
substrates. Current evidence supports the view that rhomboids pre-
dominantly, perhaps exclusively, cleave type I TMDs: those with
luminal N-termini. There is also a clear predominance of single pass
TMD  proteins in the lists of identiﬁed substrates, although a few
polytopic proteins have been reported. By their nature, intramem-
brane proteases are expected to cleave their substrates within
TMDs and, consistent with the position of the active site, all rhom-
boids cleavages to date are closer to the luminal rather than the
cytoplasmic face of the membrane. There are also a few reports
of non-canonical rhomboid cleavage of substrates just outside the
membrane or, at least in one case, in more distal luminal parts of a
substrate [10–12].
Given the importance of substrate identiﬁcation, understanding
what are the determinants that make a speciﬁc TMD  a rhomboid
substrate is essential. It is clear that there is a high level of speci-
ﬁcity – rhomboids do not cleave most TMDs – and we have a partial
picture of what is needed. A major property is helical instabil-
ity: TMDs form alpha helical secondary structure in a membrane
but rhomboid substrates tend to have residues that destabilise
helices [13]. The importance of this helical instability is high-
lighted by the observation that insertion of destabilising residues
is sufﬁcient to convert otherwise uncleavable TMDs into rhomboid
substrates [14]. Beyond helical instability, a motif around the cleav-
age site has been identiﬁed in many substrates [15]. Much greater
detail of rhomboid enzyme mechanism and substrate interaction
is reviewed elsewhere in this issue [16,17].
3. Eukaryotic secretase rhomboids
In this section we  will focus on each secretase rhomboid indi-
vidually, reviewing what is known so far about their subcellular
localisation, substrates and biological roles (Table 1 summarises
this information). It is important to note that, as with so many
protein families, the nomenclature has grown organically and is
not systematic. In particular the numbering of rhomboids in dif-
ferent species does not necessarily imply particular relationships:
for example, Drosophila Rhomboid-1 is not an orthologue of mam-
malian RHBDL1.
3.1. Drosophila rhomboids
There are ﬁve active rhomboids in the secretory pathway in
Drosophila: Rhomboid-1, -2, -3, -4, and -6 [4]. Rhomboid-1, -2, -3 are
very closely related and are adjacent to each other on chromosome
3 [18], suggesting recent gene multiplication. All three have a well
established role in EGFR signalling. Rhomboid-4 has proteolytic
activity similar to that of Rhomboid-1, -2, -3 in cell culture assays,
but has an unknown physiological role, whereas Rhomboid-6 is the
most divergent, and nothing is known of its function [4].
3.1.1. Rhomboid-1
Rhomboid-1 was the ﬁrst intramembrane serine protease dis-
covered and, to date, it is still the best-characterised catalytically-
active rhomboid. Rhomboid-1 is the primary activator of EGFR
signalling in Drosophila and thereby regulates many important
developmental decisions [18,19]. Its primary substrate is Spitz, a
ubiquitously expressed homologue of mammalian TGF [20]. Spitz
is synthesised as a type I membrane protein in the endoplasmic
reticulum (ER) and requires the protein Star for export to the Golgi.
There it is cleaved by Rhomboid-1, and its ectodomain is subse-
quently secreted as an activating ligand for the EGFR (Fig. 2) [1,2].
Apart from Spitz, which is broadly expressed, Rhomboid-1 can
cleave two  other more speciﬁcally localised EGFR ligands, Keren
and Gurken [21] although, of these, only Keren is likely to be a phys-
iological substrate. Interestingly, Rhomboid-1 was also reported to
12 V.L. Lastun et al. / Seminars in Cell & Developmental Biology 60 (2016) 10–18
Fig. 1. A secretase rhomboid and its substrate. The core rhomboid domain has six membrane spanning helices (dark blue) – the majority of secretase rhomboids have an
extra  C-terminal TMD  (light blue). The catalytic dyad is formed by the highly conserved serine and histidine in TMD4 and TMD6, respectively. The predominant class of
substrate are type I TMD-containing proteins, the majority of which are single-pass (orange).
Table 1
Secretase-type rhomboids and their proposed subcellular localisation, substrates and functions.
Protease Proposed cell compartment Proposed substrate Proposed function
Drosophila Rhomboid-1 Golgi [1,2]; endosomes [22] Spitz [1,2]; Keren [21]; Gurken
[21]; Star [22]
EGFR signalling [1,18,19]
Rhomboid-2 Golgi [21]; ER [85]; endosomes
[85]
Spitz [21]; Keren [21]; Gurken
[21,25]; Star [85]
EGFR signalling [23–25]
Rhomboid-3 Golgi [21]; ER [85]; endosomes
[85]
Spitz [21]; Keren [21]; Gurken
[21]; Star [22,85]
EGFR signalling [18]
Rhomboid-4 Golgi [21]; plasma membrane
[21]
Spitz [21,31]; Keren [21];
Gurken [21]
–
Rhomboid-6 – – –
Mammals RHBDL1 Golgi [32] – –
RHBDL2 Plasma membrane [12]; ER
[82]
Thrombomodulin [32,42];
EphrinB2/B3 [45]; EGFR [46];
EGF [12]; CLEC14A [11]
Wound healing [42];
Angiogenesis [11]
RHBDL3 Plasma membrane;
endosomes; Golgi [32,36],
– –
RHBDL4 ER [10] pTCR [10]; TCR [10],
opsin-degron [10]; Pkd1N
[10]; MPZ-L170R [10]; TSAP6
[52]; proTGF [53]; BIK1 [57]
ERAD [10]; Exosome secretion
[52]; Tumour cell growth [53];
Anti-apoptotic [53,55–58,60]
Yeast S. cerevisiae Rbd2 Golgi; plasma membrane[70] – Endocytosis [70]
S. pombe Rbd2 ER; Golgi [63] SREBP[63] Lipid metabolism [63]
Arabidopsis AtRBL1-12 Golgi (AtRBL1 and AtRBL2)
[77]; chloroplast (AtRBL8 and
AtRBL9) [78]
– Flower development, and
fertility (AtRBL2) [79];
Jasmonic acid biosynthesis
(AtRBL8 and AtRBL9) [78]
Parasites Toxoplasma gondii – multiple
rhomboids [86,87]
Microneme; mononemes;
plasma membrane; Golgi [86]
Multiple substrates – for
review see [86], and [74] in this
issue.
Host cell invasion [86]
Plasmodium spp. – multiple
rhomboids [86,87]
Microneme; mononemes;
plasma membrane [86]
Multiple substrates – for
review see [86], and [74] in this
Parasite development [86]
al
c
S
a
ﬁ
s
tEntamoeba histolytica EhROM1
[86,87]
Cell surface [86]; intern
vesicles [86]
leave and subsequently inactivate the type II membrane protein
tar, thus limiting the amount of substrate that is trafﬁcked and
dding another layer of regulation to EGFR activation [22]. If con-
rmed as a direct substrate, this would be an important and quite
urprising result: most analyses of protease active sites imply that
hey would not accommodate peptides in both orientations and, asissue.
EhGal/GalNAc lectin [86] Parasite adhesion [86]
described above, all other known rhomboid substrates are type I
TMDs.3.1.2. Rhomboid-2
Rhomboid-2 (Brho/Stet) is expressed exclusively in male and
female germ cells and, in a mechanism analogous to Rhomboid-
V.L. Lastun et al. / Seminars in Cell & Developmental Biology 60 (2016) 10–18 13
Fig. 2. Rhomboid-1 regulation of Spitz release. Spitz (green) is synthesised in the
endoplasmic reticulum and depends on the protein Star (red star) to travel to the
Golgi where it encounters Rhomboid-1 (blue). Rhomboid-1 cleaves Spitz (orange
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Fig. 3. The predominant subcellular localisation of secretase-type rhomboids in
mammals. Rhomboid proteases are located throughout the secretory endomem-
brane system. RHBDL4 (green) resides within the ER. RHBDL1 (red) mostly localisesrrow), and the resulting ectodomain is secreted as an activating EGFR ligand. This
cheme applies to ﬂy Rhomboids-1-3 and the other EGF-like ligands, Keren and
urken, with some variability in each substrate’s requirement for Star.
 activation of Spitz, is required for sending an EGF signal from
he germ cells to the surrounding somatic cells that express the
GFR [23]. Spitz and Gurken are the two EGFR ligands expressed in
erm cells; Spitz is expressed in both female and male germ cells,
hereas Gurken is expressed only in oocytes, where it is required
or egg polarization [24–26]. Ectopic expression of Rhomboid-2
ogether with Spitz or Gurken led to EGFR activation [24], consis-
ent with the observation that Rhomboid-2 can cleave both ligands
21,25]. Altogether, these suggest that Spitz and Gurken are the
atural Rhomboid-2 substrates. When misexpressed in the devel-
ping wing [24] or follicle cells [25], Rhomboid-2 and Star induce
GFR hyperactivation phenotypes in a synergistic manner imply-
ng that, as with Rhomboid-1, Star is needed to supply substrates
o Rhomboid-2 in vivo. Consistent with this, Star is expressed in
ocytes at about the same developmental stage as Rhomboid-2
24], and it is also expressed at the apical tip of the wild-type testes
23].
.1.3. Rhomboid-3
Rhomboid-3 (Roughoid) is predominantly expressed in the eye
here it contributes to EGFR signalling during development [18],
haring this function with Rhomboid-1. Spitz and Keren are pro-
osed to have overlapping function in the developing eye [27]
nd they can both be cleaved by Rhomboid-3 in cell culture [21].
pitz and Keren are functionally similar although processing of
eren is not fully dependent on Star and Rhomboid-1 [21,27,28].
lies mutant for rhomboid-3 have a rough eye phenotype [18].
homboid-3 is also expressed in a subset of neurons at the mid-
ine of the ventral nerve cord, and mutants have subtle defectswithin the Golgi apparatus. The major observed localisations for RHBDL3 (yellow)
are  endo-lysosomal membranes and the plasma membrane. RHBDL2 (blue) is prin-
cipally located at the plasma membrane.
in tracheal branching at the midline [29]. More recently, muta-
tions in rhomboid-3 were shown to result in an enlarged heart and
abnormal cardiac function in Drosophila adults [30], implying that
Rhomboid-3 also has post-developmental roles.
3.1.4. Rhomboid-4
Rhomboid-4, which is sequence divergent from Rhomboid-1, -2,
and -3, is expressed ubiquitously at low levels and localised in the
Golgi apparatus and plasma membrane [21]. Nothing is known of
its biological role, although it can cleave EGFR ligands in cell culture
assays [21]. In biochemical and cell biological studies, Rhomboid-4
has been used as an example of a rhomboid regulated by calcium
[31] (see Section 4).
3.1.5. Rhomboid-6
We  include Rhomboid-6 for completeness, but there is no pub-
lished information about its function.
3.2. Mammalian rhomboids
Unsurprisingly, there is great interest in the function of rhom-
boid proteases in mammals. The progress in this key area has been
patchy and slow, although the existing data support the importance
of rhomboids in developmental and physiological roles. There are
four rhomboid proteases, RHBDL1-4, located throughout the secre-
tory pathway in mammals (Fig. 3) [4,32]. An obvious question is
whether they, like their Drosophila counterparts, control EGFR sig-
nalling. The signiﬁcance of this question is that the EGFR is very
widely implicated in cancer, so understanding its regulation is a
priority. The simple answer appears to be that mammalian EGFR
ligands which, as in ﬂies, are synthesised as transmembrane inac-
1  Developmental Biology 60 (2016) 10–18
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Fig. 4. Regulation of rhomboid proteases by cytosolic regions of substrates. Throm-
bomodulin (orange) is cleaved within its TMD  by RHBDL2 (blue). The black arrow
indicates cleavage. An essential determinant for proteolysis is the cytosolic domain4 V.L. Lastun et al. / Seminars in Cell &
ive precursors, are liberated from their TMDs by a different family
f proteases, the ADAM metalloproteases [33]. But, as described
elow, there is a growing body of evidence to suggest that rhom-
oids may  participate, at least in some contexts. Additionally, new
ctivities and roles have been uncovered for the mammalian rhom-
oids.
.2.1. RHBDL1
RHBDL1 (also called rhomboid related protein-1) was  identiﬁed
y sequence similarity with Drosophila Rhomboid-1 [34]. Within
he mammalian rhomboids, RHBDL1 is actually most similar to
HBDL3: the murine proteins share ∼55% identity according to
lustal Omega alignment [35]. The main differences are in their
ytoplasmic N-termini, which might account for their different
ubcellular localisation: both are in the Golgi, but RHBDL3 is pre-
ominantly in endosomes and at the plasma membrane [32,36].
ccording to public databases and transcriptome-wide analyses,
HBDL1 is highly expressed in neurons [37,38]. To date, no RHBDL1
ubstrates have been identiﬁed and its biological role is unknown.
.2.2. RHBDL2
RHBDL2 is the best-characterised mammalian rhomboid pro-
ease and a number of substrates have been reported. It is localised
t the plasma membrane and shares proteolytic speciﬁcity with
rosophila Rhomboids-1-3, being able to cleave Drosophila Spitz
32] and Gurken [39]. Although this represents a non-physiological
ctivity, it is unique amongst the mammalian rhomboids, and has
erved as a starting point for substrate identiﬁcation. We now
escribe the RHBDL2 substrates that have been identiﬁed.
.2.2.1. EGF. Based upon the Drosophila rhomboid role in EGFR
ignalling, the mammalian proteases were screened for activity
gainst various EGF-like ligands. RHBDL2 cleaves EGF itself, but no
ther related ligands, at a luminal region close its transmembrane
omain. The soluble product which, due to the different cleavage
ite, is distinct from that produced by its major processing enzyme
DAM10, is sufﬁcient to engage and activate the EGFR [12]. RHBDL2
leavage of EGF is only observed upon inhibition of metalloprotease
ctivity, suggesting that it may  be only a minor contributor to EGF
hedding, or occurs only in cells without ADAM10. In the absence of
upporting functional evidence, these results formally only prove
hat RHBDL2 can cleave EGF, not that it does so in a physiologi-
ally meaningful way. It is notable, however, that several cancer
ell lines have enhanced RHBDL2-driven EGF cleavage, suggesting
 potential pathological role in mammalian EGFR signalling [12,40].
.2.2.2. C-type lectin family members – thrombomodulin and
LEC14a. The ﬁrst mammalian rhomboid substrate to be identiﬁed
as the lectin and EGF-like domain containing protein thrombo-
odulin [32]. Thrombomodulin is an anti-coagulant that converts
hrombin from its pro- to anti-coagulant form [41], with roles in
ngiogenesis and inﬂammation. Unlike most rhomboid substrates,
hrombomodulin does not require helix-destabilising residues in
ts TMD  to be cleaved by RHBDL2: instead, its cytosolic domain
cts as a cleavage determinant (Fig. 4A). Indeed, the cytoplasmic
egion of thrombomodulin is sufﬁcient to transform otherwise non-
leavable proteins into rhomboid substrates [32]. More recently,
he biological signiﬁcance of this cleavage was suggested by obser-
ations that RHBDL2 is required for thrombomodulin shedding
uring in vitro scratch-wound assays. Moreover, in a mouse model,
HBDL2 is upregulated after transdermal wound formation, and
hrombomodulin shedding is instrumental to closure of the wound
nd subsequent healing [42], suggesting that RHBDL2 may  have a
ole in endothelial and immune cells.
A potential role for RHBDL2 in endothelia is further supported by
he cleavage of C-type Lectin 14A (CLEC14a) [11], another memberof  thrombomodulin. (B) RHBDL4 (green) binds ubiquitinated ERAD substrates
(orange) via a C-terminal ubiquitin-interaction motif. RHBDL4 cleaves at least some
substrates at multiple sites, promoting their degradation (black arrows).
of the thrombomodulin family. CLEC14a is speciﬁcally and highly
expressed in endothelial cells and mouse vasculature, where it
plays roles in cell-cell adhesion and angiogenesis [43]. CLEC14a is
cleaved by RHBDL2 in a luminal region close to its transmembrane
domain, mirroring RHBDL2 cleavage of EGF. Similar to thrombo-
modulin, the cytoplasmic domain of CLEC14a is essential for its
cleavage by RHBDL2. A role in angiogenesis for RHBDL2 in rela-
tion to CLEC14a cleavage has been postulated, and in cell culture,
RHBDL2 depletion strongly affects endothelial cell migration [11].
3.2.2.3. B-type ephrins. B-type ephrins are ligands for Eph recep-
tors, which are the largest family of receptor tyrosine kinases [44].
Based upon amino acid identity between ephrin B2 and the lumi-
nal region of Spitz, it was  found that membrane anchored B-type
ephrins are RHBDL2 substrates, and are cleaved within their TMDs
[45]. In this case, the cleavage follows the conventional pattern:
the TMDs of B-type ephrins contain all the required information
for RHBDL2 cleavage; their cytoplasmic domains are not required.
Despite the efﬁciency of this cleavage by RHBDL2, no physiological
signiﬁcance for it has yet been reported.
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.2.2.4. EGFR. The EGFR itself has also been shown to be cleaved
y RHBDL2 [46], further elaborating the complex relationship
etween rhomboids and EGFR signalling. EGF stimulation triggers
leavage of the EGFR. This process is increased by over-expression
f RHBDL2 and is sensitive to the serine protease inhibitor
ichloroisocoumarin [46], which has previously been used for inhi-
ition of rhomboid protease activity [1,39,47]. Importantly, as in
ost other cases, the biological signiﬁcance of EGFR cleavage by
HBDL2 still needs to be clariﬁed.
.2.3. RHBDL3
RHBDL3 (also called ventrhoid) localises to the Golgi apparatus,
s well as endosomes and plasma membrane [32,36]. RHBDL3 is
ighly expressed in the nervous system [48] and, consistent with
his, was identiﬁed as a candidate gene involved in the onset of
ental retardation in neuroﬁbromatosis type 1 (NF1) microdeleted
atients [49]. Furthermore, in a study searching for genes that
hange expression levels in association with chronological age in
uman brain, RHBDL3 showed the most consistent age-associated
hange in expression [50]. No substrates have been reported for
HBDL3. RHBDL3 has predicted EF-hands in its cytoplasmic N-
erminal domain [31], suggesting the possibility that it is regulated
y calcium binding, similarly to Drosophila Rhomboid-4.
.2.4. RHBDL4
RHBDL4 (also called RHBDD1) is the only mammalian rhomboid
rotease resident in the ER and is upregulated upon ER stress [10].
t is phylogenetically divergent from RHBDL1-3 and, unlike them
nd Drosophila rhomboids, RHBDL4 has six TMDs instead of seven
4]. Several functions have been reported for RHBDL4.
.2.4.1. RHBDL4 and ER-associated degradation. Fleig et al. [10]
howed that RHBDL4 binds via a ubiquitin interaction motif to
biquitinated substrates of ER-associated degradation (ERAD),
ncluding the  chain of the pre-T cell receptor (pTCR).  This bind-
ng is coupled to substrate proteolysis and degradation. RHBDL4
leaved pTCR within its TMD  but also at other sites within
he ectodomain, far from the membrane. RHBDL4 also cleaved
ther unstable membrane proteins – mutants containing helix-
estabilizing amino acids or degron motifs in their TMDs – but not
heir wild-type counterparts (Fig. 4B). Uncommonly for rhomboid
roteases, among the destabilized substrates some were poly-
opic proteins, which were cleaved within loops or juxtamembrane
egions of their TMDs. These data suggest a role for RHBDL4 in ERAD
lthough, since it is not part of the core ERAD machinery, it is not yet
lear what the normal substrates are, nor in what context RHBDL4
cts.
.2.4.2. RHBDL4 and exosomal secretion. Another potential RHBDL4
ubstrate is TSAP6, a six-TMD protein that plays a role in exosomal
ecretion [51]. It has been suggested that RHBDL4 regulates exo-
omal secretion by cleaving and inactivating TSAP6 [52]. RHBDL4
leaved TSAP6 at three sites and, given the more recently proposed
ole for RHBDL4 in ERAD, this raises the question of whether TSAP6
s an ERAD substrate. Not only is TSAP6 a potential polytopic sub-
trate, but also the primary cleavage site is in a TMD  with type II
opology. As in the case of Star [22] described above, this orienta-
ion of the substrate potentially implies that some rhomboids can
leave type II TMDs.
.2.4.3. RHBDL4 and TGF˛. Recently, Song et al. [53] reported that
HBDL4 is implicated in colorectal cancer (CRC). Elevated RHBDL4
xpression correlated with poor prognosis in human CRC, and
HBDL4 depletion led to a decrease of tumour growth in a mouse
odel. Elevated RHBDL4 correlated with EGFR activation. It was
roposed that this was caused by RHBDL4 promoting the cleavagelopmental Biology 60 (2016) 10–18 15
and subsequent secretion of the EGFR ligand TGF, a mechanism
that would be analogous to Drosophila Rhomboid-1 cleaving Spitz.
This mechanism, but not RHBDL4′s implication in CRC, has subse-
quently been challenged in a paper reporting that RHBDL4 cannot
cleave TGF, but instead promotes the cellular export of full-length
pro-TGF in exosomes [54]. These very recent papers on TGF
clearly need further resolution but the message that RHBDL4 par-
ticipates in some way in CRC ﬁts into a growing pattern of links
between rhomboid-like superfamily and cancer.
3.2.4.4. RHBDL4 and apoptosis. High RHBDL4 expression levels
have been reported in a range of cancer cell lines or tissues.
Conversely, loss of RHBDL4 is associated with a decrease in cell
proliferation, colony formation, and tumour growth, as well as
increased apoptosis in human glioblastoma, hepatoma HepG2 cells,
and human colorectal cancer [53,55–58]. Anti-apoptotic activity is
a trait of cancer [59], however, RHBDL4 has not been proved to
regulate this postulated role directly, although Wang et al. [57]
reported a role for RHBDL4 in degrading the pro-apoptotic protein
BIK, and Ren et al. [60] proposed that RHBDL4 can regulate apopto-
sis by inﬂuencing the levels and activity of c-Jun and subsequently
of Bcl-3.
3.3. Yeast rhomboids
Two  predicted rhomboid proteases are present in Saccharomyces
cerevisiae, Rbd2p and Pcp1p/Rbd1p (the mitochondrial rhomboid)
[61]. In the distantly related ﬁssion yeast, Schizosaccharomyces
pombe, there are four predicted rhomboid proteases according to
the public source database PomBase [62], two of which are pre-
dicted to be mitochondrial [63].
3.3.1. S. cerevisiae Rbd2p
RBD2 is not an essential gene, and its loss in S. cerevisiae leads
to no obvious growth defects [61]. According to two  transmem-
brane domain prediction servers, Phobius [64] and TMHMM [65],
Rbd2p is predicted to have an unusual ﬁve TMD structure, with
a conserved catalytic serine in its fourth transmembrane helix. No
substrate has been discovered for Rbd2p but, if these predictions are
accurate (note that such prediction methods are not very reliable),
this unusual topology would suggest distinct enzymology. Multiple
large-scale screens have revealed that Rbd2p interacts genetically
and physically with regulators of vesicular trafﬁc and the actin
cytoskeleton [66–69]. These observations ﬁt well with recent data
demonstrating that Rbd2p negatively regulated the timing of actin
assembly during clathrin-mediated endocytosis [70] by altering the
distribution of phosphatidylinositol 4,5-bisphosphate (PIP2), a key
determinant of this process. This is the ﬁrst demonstration that a
rhomboid can regulate the distribution of a speciﬁc species of lipid.
The cytoplasmic tail of Rbd2p was sufﬁcient to bind PIP2 and reg-
ulate actin assembly in vivo, implying that this role is independent
of potential proteolytic activity. Notably, general endocytic uptake
was not drastically affected in RBD2 knockout strains.
3.3.2. S. pombe Rbd2
S. pombe Rbd2 is not an orthologue of the rhomboid in S. cere-
visiae with the same name, and is predicted to have a classical
six-TMD structure with a conserved catalytic dyad (according to
TMHMM  [65] and Phobius [64]). It has recently been reported that
S. pombe Rbd2 has a key role in lipid homeostasis by process-
ing the sterol regulatory element-binding protein (SREBP) [63,71].
SREBP is a membrane tethered transcription factor that in meta-
zoans is released from the Golgi membrane by site-2-protease (S2P)
(an intramembrane metalloprotease, unrelated to rhomboids) to
become an active transcription factor [72]. There are no homo-
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ogues of S2P in S. pombe; instead Rbd2 performs this function
63].
.4. Rhomboids in apicomplexan parasites
Sequence similarity to the Drosophila rhomboid substrate Spitz,
dentiﬁed Toxoplasma gondii surface antigens involved in para-
ite adhesion and invasion as rhomboid substrates [13]. Much has
ubsequently been published about the role of rhomboids in api-
omplexan parasites, including the malaria parasite Plasmodium
73]. Parasite species tend to have a large number of rhomboids,
nd multiple substrates have been identiﬁed. The functional roles
f these rhomboids are complex and varied and are described in
etail in another review in this issue [74].
.5. Plant rhomboids
The number of rhomboid genes in plants ranges from four in
he green alga Ostreococcus lucimarinus to twenty-ﬁve in soybean,
lycine max  [75]. Recent sequence analysis indicates that, as in
nimal rhomboids, some contain recognisable additional motifs,
ncluding cysteine-rich, ubiquitin-binding or RanBP-type Zinc ﬁn-
er motifs [75]. Arabidopsis thaliana has 17 rhomboid genes, of
hich twelve, AtRBL1-12,  are predicted to encode for active, non-
itochondrial rhomboids [4,76]. AtRBL1 and AtRBL2 are in the
olgi apparatus, and AtRBL2 has similar enzymatic activity to
rosophila rhomboids in that it can cleave Spitz and Keren [77].
tRBL8 and AtRBL9 are localised in the chloroplast inner envelope
78]; the localisation of the rest has not been reported. AtRBL8 has a
ole in ﬂower development, and fertility [79]. The double knockout
f AtRBL8 and AtRBL9 decreases allene oxide synthase (AOS), an
nzyme involved in biosynthesis of jasmonic acid [78]. Jasmonate
egulates auxin synthesis and transport [80], providing a possi-
le explanation of the ﬂower and fertility phenotypes in AtRBL8
utants [79].
. Regulation
Proteolysis is an irreversible process and its consequences range
rom protein degradation to the production of important functional
olecules such as untethered transcription factors and signalling
omponents. This implies that proteases are potentially dangerous
nd must be tightly regulated. We  currently have only a patchy
nowledge of rhomboid regulation, but some themes do emerge.
 key difference between intramembrane proteases and classical
oluble proteases is that in the case of the former, both the enzyme
nd the substrate are membrane proteins. This implies that they
an only interact if they are present in the same membrane, and
his allows for regulation by compartmentalisation. The best exam-
le of this is the case of Drosophila Spitz being trapped in the ER,
nd therefore inaccessible to the Golgi-localised rhomboids, until
tar supports its onward trafﬁcking [2]. Drosophila Rhomboids-1-3
re also tightly transcriptionally regulated [18], and although this
annot provide the kind of acute control needed in cells, when com-
ined with compartmentalisation, these two mechanisms appear
o provide the core regulation of the most studied Drosophila
homboid proteases. Interestingly, in the case of the S. cerevisiae
itochondrial rhomboid, Rbd1p, its substrate, the GTPase Mgm1p,
as developed a different way of segregating its substrate TMD  from
he rhomboid. Mgm1p  has a primary TMD  that is not a substrate
or Rbd1p and a secondary hydrophobic domain, containing the
leavage site, which resides out of the bilayer until it is pulled into
he plane of the membrane by an ATP-dependent process. Only
hen can Mgm1p  be cleaved [81]. Although a very different mech-
nism to that regulated by Star in Drosophila,  both are examples of
egulating substrate accessibility to the protease.lopmental Biology 60 (2016) 10–18
A second theme in rhomboid regulation is the role of their cyto-
plasmic domains in modulating enzyme activity. The cytoplasmic
N-terminal domain of Drosophila Rhomboid-1 is not required for
enzyme activity [1] and much further evidence has accumulated
that the conserved six-TMD rhomboid-like domain is sufﬁcient for
proteolysis. The cytoplasmic domains are less well conserved and
frequently have recognisable other motifs, making them attrac-
tive candidates for regulatory modules. In one case, this has been
shown explicitly to be the case. Drosophila Rhomboid-4, whose bio-
logical function is not yet known, is an example of a rhomboid
protease with EF-hands in its cytoplasmic N-terminus. Baker et al.
[31] showed that calcium binding by the cytosolic loops controlled
substrate cleavage by modulating access or gating to the active site.
Another way  of regulating enzymes is by post-translational
modiﬁcations. It has been reported that proteolytic processing of
RHBDL2 is required for its activity against Spitz [82]. A cleaved form
of RHBDL2 is detected in cells, and an uncleavable mutant has no
catalytic activity and is retained in the ER. The cleavage depends on
a highly conserved tryptophan-arginine motif in the ﬁrst luminal
loop. However, current evidence does not support the interpre-
tation that this cleavage is equivalent to activation of an inactive
zymogen form of the enzyme: the L1 loop, which is separated from
the catalytic core of the enzyme upon this cleavage, is necessary for
stabilising the core rhomboid-like fold. It therefore appears more
likely that the mutations in L1 loop destabilise RHBDL2, leading to
its inactivity and retention in the ER.
The intimate relationship between polytopic membrane pro-
teins and the lipid bilayer indicates that lipids might also regulate
rhomboid activity. This is an understudied area but there is good
evidence to support the idea that membrane lipids can regulate
rhomboids. Rhomboid activity was  modiﬁed by varying lipid con-
stitution in vitro [47]. The interaction with the membrane also
affects the conformation of both the rhomboid active site and the
substrate TMD, thereby inﬂuencing cleavage [14]. In addition, com-
pounds that perturb the lipid composition of the membrane bilayer
reduce the speciﬁcity of rhomboids, allowing non-substrates to be
cleaved [14]. These experimental observations are supported by
molecular dynamics analysis [83]; they are also consistent with
the structural observation that the hydrophobic core of at least
the E. coli rhomboid GlpG is unusually thin, suggesting unusual
interactions with surrounding lipids [84].
5. Conclusion
The secretase rhomboids are the most numerous eukaryotic
class of this universally conserved family of enzymes, yet we still
know quite little about the range and signiﬁcance of their bio-
logical functions. This knowledge gap is perhaps most striking in
the case of mammalian rhomboids, where there is mounting evi-
dence to implicate them in human disease. In this review we have
attempted to present a concise encyclopaedia of secretase rhom-
boids. Beyond the trivial point that they need more study, perhaps
the main conclusion that emerges is the importance of identify-
ing their natural substrates: that will be the key to understanding
their biological signiﬁcance. Knowing which proteins rhomboids
can cleave is a good start but is not the same as knowing which pro-
teins are substrates in real biological contexts. Unfortunately, there
is no simple pipeline for protease substrate identiﬁcation. Instead, a
combination of genetic, proteomic, biochemical, and bioinformatic
approaches are needed. The good news is that, as methods in all
these areas become more sophisticated, there is a good prospect
of making substantial progress in the near future. Of course, the
possibility that rhomboids will participate in pathological events
underlies the search for speciﬁc inhibitors – reviewed in this issue
[17]. Whole new families of enzymes – inherently more drug-
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able than protein-protein interactions – are not discovered very
requently, and the rhomboids remain one of the most recently
dentiﬁed. It may  not be long before we can begin to review their
edical utility.
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